Cargando…
Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium
In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997–2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999–2009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant...
Autores principales: | Van Heirstraeten, Liesbet, Coenen, Samuel, Lammens, Christine, Hens, Niel, Goossens, Herman, Malhotra-Kumar, Surbhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437719/ https://www.ncbi.nlm.nih.gov/pubmed/22932671 http://dx.doi.org/10.3201/eid1809.120049 |
Ejemplares similares
-
Macrolide- and Telithromycin-resistant Streptococcus pyogenes, Belgium, 1999–2003
por: Malhotra-Kumar, Surbhi, et al.
Publicado: (2005) -
Remarkable Genome Stability among emm1 Group A Streptococcus in Belgium over 19 Years
por: Coppens, Jasmine, et al.
Publicado: (2019) -
Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes
por: Albrich, Werner C., et al.
Publicado: (2004) -
Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19–December 31, 2021
por: Kremer, Cécile, et al.
Publicado: (2022) -
Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022
por: Van Heirstraeten, Liesbet, et al.
Publicado: (2022)